Winton Group LTD Axonics, Inc. Transaction History

Winton Group LTD

  • $1.35 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Jul 21, 2021
SELL
$49.14 - $59.89 $716,756 - $873,555
-14,586 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$42.19 - $51.5 $1.58 Million - $1.93 Million
-37,380 Reduced 71.93%
14,586 $728,000
Q3 2020

Oct 30, 2020
BUY
$35.33 - $51.04 $1.84 Million - $2.65 Million
51,966 New
51,966 $2.65 Million

Others Institutions Holding AXNX

# of Institutions
17
Shares Held
5.03M
Call Options Held
0
Put Options Held
0
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email